This information was published on 2026-10-19T09:10:18 for IP Right Registration Published.
| Field | Value |
| (210) | 2634107 |
| (220) |
10 Mar 2026
|
| (511) (510) |
Class 5
Pharmaceutical compositions and preparations for the treatment of neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Pharmaceutical compositions and preparations for the treatment of amyotrophic lateral sclerosis (ALS), Parkinson's disease, multiple sclerosis (MS), Huntington's disease (HD), Friedreich's ataxia (FA), Alzheimer's disease, motor neuron disease, cognitive disorders, memory impairment, and memory deficit. Class 42 Providing medical and scientific research information in the field of pharmaceuticals; Hosting a website featuring research information related to neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Hosting a website featuring consumer information related to neuropathic pain, neurodegenerative diseases, neurological conditions, and degenerative brain diseases; Research and development of pharmaceuticals; Research and development of technology in the field of pharmaceuticals; Pharmaceutical drug development services |
| (540) |
|
| (550) | Figurative |
| (730) |
Repeat Therapeutics, Inc.
|
| (750) |
Bespoke
|
Find out more about publications on the About page.